Sartorius Competitive Intelligence & Landscape

Sartorius (sartorius.com) is a prominent international partner specializing in solutions for the biopharmaceutical industry and laboratories, headquartered in Göttingen, Germany [source]. The company's core mission revolves around enabling its customers to safely, timely, and economically develop and produce drugs [source]. They offer a wide array of products and services, including biolayer interferometry, bioreactors and fermenters, cell culture media, fluid management, high-throughput screening by cytometry, live-cell imaging and analysis, lab equipment and supplies, lab weighing, nucleic acid delivery solutions, process analytical technology (PAT), process chromatography, process filtration, and surface plasmon resonance [source].

Sartorius serves a target market that spans biopharma, laboratory, applied, and life sciences. The company continually expands its portfolio through acquisitions of complementary technologies and has historically demonstrated double-digit annual growth [source]. A key part of its strategy involves a strong focus on biopharma [source].

The Sartorius Group operates with two separately listed entities: Sartorius AG and Sartorius Stedim Biotech S.A. [source]. While Sartorius AG is the parent company based in Göttingen, Germany [source], Sartorius Stedim Biotech S.A. is headquartered in Aubagne, France, and has over 9,900 employees worldwide, with Sartorius AG holding approximately 71.5% of its share capital and around 83% of its voting rights [source]. The company is actively investing in new competence centers, such as one for cell and gene therapy components in Freiburg, Germany [source].

Sartorius emphasizes simplifying progress and corporate governance that aligns with stakeholder interests, lawful and responsible conduct, and constructive cooperation [source] [source]. The company also demonstrates a commitment to sustainability, highlighted by initiatives like the New Light Pack Tip Box designed to reduce plastic waste and CO₂ emissions [source]. With around 60 production and sales sites globally, Sartorius maintains a strong international presence [source].

Sartorius (sartorius.com) offers a wide array of laboratory equipment and services, with pricing and quotes available directly through their website. Customers can access resources for pricing information, quote requests, and managing existing quotes [1]. For instruments, Sartorius provides various service plans, such as the Preventive Plan for uninterrupted performance with comprehensive expense coverage and the Lightning Plan for expedited on-site service for mission-critical instruments [2].

The company's product range includes various laboratory balances. For example, the Entris® II Advanced Line Analytical Balances with Internal Adjustment, 0.1 mg, is priced at $3,990.00 USD [4]. Other balance types include Cubis® II Balances, which are modular premium laboratory balances [6], and Quintix® Lab Balances, known for their intuitive touchscreen interface and built-in application programs [8]. The Cubis® II Advanced Semi-Micro Balance also includes a motorized draft shield, ionizer, and software package, featuring compliance with 21 CFR Part 11 and EU Annex 11 [3].

Sartorius also offers advanced electronic pipettes, such as the Picus® NxT Electronic Pipette, Single Channel, which provides enhanced ergonomics and advanced functionality for pipetting needs [5]. While some products like the Entris® II balances have listed prices [4], many other products, particularly for custom or bulk orders, require customers to request a quote [6, 8]. The Quintix® and Secura® Standard Laboratory Balances are highlighted as cost-effective solutions for budget-conscious labs, offering versatile performance [9].

Sartorius demonstrates a consistent focus on talent acquisition to support its diverse operations in biopharma, laboratory, and life sciences. The company actively maintains a dedicated careers section on its website, providing a central portal for job opportunities globally and emphasizing its commitment to building a global team sartorius.com/en/company/careers/vacancies-job-opportunities.

Recent job postings highlight strategic growth areas and a need for specialized expertise. For instance, Sartorius is actively recruiting for roles such as "Technical Sales Specialist" in the San Francisco Bay Area, focusing on driving sales for mid-size and large accounts [sartorius.com/en/company/careers/vacancies-job-opportunities/technical-sales-specialist-san-francisco-bay-area-san-francisco-bay-area-ca-united-states-of-america-1830178]. Another key opening is a "Head of Business Development - Cell and Gene Therapy" for the Eastern or Central U.S., indicating a significant investment in expanding its commercial infrastructure within this critical sector [sartorius.com/en/company/careers/vacancies-job-opportunities/head-of-business-development-cell-and-gene-therapy-eastern-or-central-u-s-home-office-united-states-of-america-1806754]. The company also seeks a "Field Application Specialist - Fluid Management Technologies (Single Use)" in remote U.S. locations, underscoring its focus on customer support and specialized technology [sartorius.com/en/company/careers/vacancies-job-opportunities/field-application-specialist-fluid-management-technologies-single-use-remote-tx-co-ks-home-office-united-states-of-america-1798546].

Beyond sales and specialized applications, Sartorius is also strengthening its internal support systems, as evidenced by a "Labor & Employment Relations Manager" position in Bohemia, NY, which is responsible for providing strategic legal guidance across North America, Canada, LATAM, and Puerto Rico [sartorius.com/en/company/careers/vacancies-job-opportunities/labor-employment-relations-manager-bohemia-ny-united-states-of-america-1791936]. Furthermore, a role for an "Expert Product Compliance & Hazardous Substances" in Goettingen, Germany, reflects the company's commitment to global chemical regulatory compliance for its products [sartorius.com/en/company/careers/vacancies-job-opportunities/expert-product-compliance-hazardous-substances-x-f-m-goettingen-1819376].

These hiring patterns signal a strategic direction centered on growth, particularly in key markets and advanced therapy segments like cell and gene therapy, as well as a strong commitment to regulatory compliance and customer support. The availability of diverse roles, from entry-level positions for career starters to opportunities for experienced professionals, indicates a robust and expanding workforce across various functions and geographies sartorius.com/en/company/careers/career-starters, sartorius.com/en/company/careers/professionals. No information regarding layoffs was found within the provided sources, suggesting a stable or growing employment trend at this time.

Sartorius (sartorius.com) is a biopharma sector partner that has demonstrated consistent double-digit growth on average, regularly expanding its portfolio through strategic acquisitions [sartorius.com/en/company/sartorius-ag-investor-relations]. For fiscal year 2025, the company reported sales revenue of €3,538.1 million, marking a 7.6% increase in constant currencies compared to the prior year [sartorius.com/en/company/investor-relations/fy-2025-sag]. This growth was driven by positive developments in both its Bioprocess Solutions and Lab Products & Services divisions, particularly a significant increase in recurring business with consumables [sartorius.com/en/company/newsroom/corporate-news/preliminary-full-year-results-2025-sartorius-group-1793940].

The company's profitability has also shown an upward trend. The Underlying EBITDA for fiscal year 2025 reached €1,051.6 million, with the Underlying EBITDA Margin increasing by 1.7 percentage points to 29.7% [sartorius.com/en/company/newsroom/corporate-news/preliminary-full-year-results-2025-sartorius-group-1793940]. The relevant net profit stood at €330.7 million, and earnings per ordinary share were €4.78 [sartorius.com/download/1796536/fy-2025-download-annual-report-sag-en-data.pdf]. Looking ahead to fiscal year 2026, Sartorius anticipates a continuation of its profitable growth trajectory [sartorius.com/en/company/investor-relations/fy-2025-sag].

In the first three months of 2026, Sartorius Group continued its growth, reporting sales revenue of €899 million, a 7.5 percent increase in constant currencies compared to the prior-year quarter [sartorius.com/download/1817684/q1-2026-download-earnings-report-sag-en-data.pdf]. This was primarily fueled by strong recurring business in consumables and services across both divisions. The company's market capitalization was approximately €15.1 billion in fiscal year 2025 [sartorius.com/en/company/investor-relations/fy-2025-sag].

Sartorius maintains its focus on the high-growth biopharma market, supported by a broad product offering and a strong global presence [sartorius.com/download/1796538/fy-2025-download-ir-fact-sheet-sag-en-data.pdf].

Sartorius (sartorius.com) actively engages with the scientific and biopharmaceutical communities through a variety of event participations, including exhibitions, conferences, and dedicated Sartorius Day events. They maintain a comprehensive section on their website for Exhibitions and Conferences Around the World [1]. This includes major industry gatherings such as the BIO International Convention in June 2026, where they will connect with experts to discuss integrated technologies and digital tools for therapy development [6].

Sartorius also hosts specialized local events, providing focused opportunities for engagement. Examples include Sartorius Day Lisbon on March 18, 2026, offering attendees a chance to meet technical specialists and explore advancements in upstream and downstream processes [3]. Similarly, Sartorius Day Toulouse on November 4, 2025, will feature informative sessions and discussions on accelerating production in the biopharmaceutical industry [9]. The company also organizes exclusive events like the Fill & Finish Days in Aubagne, France, from September 30 to October 1, 2025, which will bring together industry leaders to discuss final formulation and filling regulations [7], and the Sartorius PI Forum, focusing on topics such as flexible manufacturing and digitalization [4].

Beyond their own events, Sartorius participates in prominent industry conferences, showcasing their expertise and solutions. This includes attending Antibody Engineering and Therapeutics from December 14-17, 2025, to discuss solutions for antibody development [5], and the SLAS Europe 2025 Conference and Exhibition in Hamburg, Germany, from May 20-22, uniting the European life sciences and laboratory technology community [8].

In addition to in-person events, Sartorius offers extensive Life Science Webinars, providing educational content on various topics. These webinars, available both live and on-demand, deliver expert knowledge to enhance workflow [2]. They also feature specialized webinar collections, such as those focused on Process Intensification, offering best practices and critical insights [10].